Pharmaceutical composition, excipient for the composition and use of the composition
US11389423B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignees
Inventors
- Luiz Donaduzzi
- Carmen Maria Donaduzzi
- Liberato Brum Junior
- Patricia Moura Da Rosa Zimmerman
- Emanuelle Webler
- Leticia Mello Rechia
- Jose Alexandre de Souza Crippa
- Jaime Eduardo Cecilio Hallak
- Antonio Waldo Zuardi
- Francisco Silveira Guimaraes
- Alline Cristina De Campos
- Vitor Tumas
- Elaine Aparecida Del Bel Belluz Guimarães
Key dates
| Filing date | Feb 11, 2019 |
| Grant date | Jul 19, 2022 |
| Priority date | — |
| Expiry date | Mar 2, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0053
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition containing synthetic Cannabidiol and its use in obtaining a medication for the treatment of neurological disorders, as well as the main excipients used in the production process, in addition to its small, medium, and large-scale preparation process. The use of the composition for the treatment of neurological disorders in human or animal populations, in particular in the treatment of Parkinson's disease, in the range of 300 to 850 mg/day or at daily doses of 100 to 1750 mg for neuroprotective action.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.